Chemotherapy Induced Nausea and Vomiting (CINV) Existing and Pipeline Drugs Market Is Expected to Reach USD 2.1 Billion Globally in 2018: Transparency Market Research
CINV market was worth USD 1.3 billion in 2011 and is expected to reach USD 2.1 billion in 2018, growing at a CAGR of 7.1% from 2013 to 2018. The North American CINV existing and pipeline drugs market is expected to reach USD 1.0 billion in 2018. Sluggish economic growth and a poor reimbursement scenario in European countries have hampered the growth of CINV drugs market in these regions.
View full press release